O. Rick

发表

Chemotherapy in patients with metastatic or relapsed germ-cell tumours.

W. Siegert, O. Rick, J. Beyer, 2001, Cancer treatment reviews.

First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial

C. Bokemeyer, L. Kanz, N. Schleucher, 2003, British Journal of Cancer.

Recommendations from the society for diagnosis and therapy of haematological and oncological diseases Guideline Breast Cancer in Women

R. Greil, C. Bokemeyer, N. Harbeck, 2016 .

Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor.

W. Siegert, O. Rick, J. Beyer, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Oncological Rehabilitation

O. Rick, T. Dauelsberg, Eva-Maria Kalusche-Bontemps, 2017, Oncology Research and Treatment.

Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages

G. Kristiansen, D. Beyersdorff, P. Albers, 2021, Urologia Internationalis.

Leukapheresis after high‐dose chemotherapy and autologous peripheral blood progenitor cell transplantation: a novel approach to harvest a second autograft

O. Rick, N. Ahrens, A. Salama, 2003, Transfusion.

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

S. Fosså, S. Culine, A. Horwich, 2008, European urology.

Influence of amifostine on reconstitution of lymphocyte subpopulations after conventional- and high-dose chemotherapy in patients with germ cell tumor

W. Siegert, O. Rick, J. Beyer, 2002, Annals of Hematology.

Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.

P. Albers, U. Pichlmeier, M. Kuczyk, 2005, The Journal of urology.

[Lymphedema in patients with breast cancer--a consensus regarding diagnostics and therapy in patients with postoperative lymphedema after primary breast cancer].

O. Rick, U. Seifart, J. Hübner, 2007, Die Rehabilitation.

Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization

D. Huhn, W. Siegert, O. Rick, 2000, Annals of Hematology.

First-Line and Salvage High-Dose Chemotherapy in Patients with Germ-Cell Tumors

W. Siegert, O. Rick, J. Beyer, 2003 .

Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.

W. Siegert, C. Bokemeyer, L. Kanz, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors

C. Bokemeyer, K. Oechsle, F. Mayer, 2007, Anti-cancer drugs.

Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.

C. Bokemeyer, J. Hartmann, C. Kollmannsberger, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Superior survival after sequential high-dose chemotherapy (HDCT) as compared to single HDCT in patients with relapsed or refractory germ cell tumors (GCT): Six-year long-term follow-up of a prospective, randomized phase II trial.

C. Bokemeyer, A. Kramar, O. Rick, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activity of thalidomide in patients with platinum-refractory germ-cell tumours.

W. Siegert, O. Rick, J. Beyer, 2006, European journal of cancer.

Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.

W. Siegert, C. Bokemeyer, L. Weissbach, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.

C. Bokemeyer, J. Hartmann, O. Rick, 2010, The Journal of urology.

Salvage chemotherapy in relapsed germ cell tumors

W. Siegert, C. Bokemeyer, O. Rick, 2001, World Journal of Urology.

Bacterial Contamination of Autologous Bone Marrow: Reinfusion of Culture-Positive Grafts Does Not Result in Clinical Sequelae during the Posttransplantation Course

D. Huhn, H. Heuft, O. Rick, 1998, Vox Sanguinis.

Preparation of autologous bone marrow grafts for cryopreservation using the AS104 cell separator

D. Huhn, H. Heuft, R. Blasczyk, 1997, Journal of clinical apheresis.

Analysis for Recovery and Loss of Mononuclear Cells and Colony‐Forming Units Granulocyte‐Macrophage during ex vivo Processing of Autologous Bone Marrow

D. Huhn, H. Heuft, R. Blasczyk, 1996, Vox sanguinis.

Statement from the Consensus Conference on Anti-D Prophylaxis

J. Byrd, D. Huhn, W. Quint, 1998, Vox Sanguinis.

Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution

D. Huhn, W. Siegert, O. Rick, 1995, Annals of Hematology.

Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.

D. Huhn, W. Siegert, H. Heuft, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Microbiologic Contamination of Peripheral Blood Stem Cell Autografts

W. Siegert, H. Heuft, R. Blasczyk, 1994, Vox sanguinis.

NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer

K. Fliessbach, H. Hass, C. Hoppe, 2017, Psycho-oncology.

Peripheral Blood Progenitor Cell Collection during Hematopoietic Recovery following Autologous Blood Progenitor Cell Transplantation

D. Huhn, W. Siegert, H. Oettle, 1997, Vox sanguinis.

Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome.

D. Huhn, W. Siegert, O. Rick, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

PBPC mobilization with paclitaxel, ifosfamide, and G‐CSF with or without amifostine: results of a prospective randomized trial

W. Siegert, O. Rick, J. Beyer, 2001, Transfusion.

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

W. Siegert, N. Kröger, A. Zander, 2002, Haematologica.

The role of high-dose chemotherapy in relapsed germ cell tumors

W. Siegert, C. Bokemeyer, C. Kollmannsberger, 2004, World Journal of Urology.

Current aspects of high-dose chemotherapy in germ-cell tumors.

C. Bokemeyer, C. Kollmannsberger, O. Rick, 2003, Critical reviews in oncology/hematology.

High-dose chemotherapy as salvage treatment for seminoma

W. Siegert, O. Rick, J. Beyer, 2002, Bone Marrow Transplantation.

High-dose chemotherapy with autologous stem cell support in poor-risk germ cell tumors

W. Siegert, O. Rick, J. Beyer, 1998, Annals of Hematology.

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).

W. Siegert, S. Fosså, S. Culine, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

S. Fosså, S. Culine, A. Horwich, 2008, European urology.

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

S. Fosså, A. Horwich, R. Huddart, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome

W. Siegert, O. Rick, J. Beyer, 1997, Bone Marrow Transplantation.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer

M. Lux, M. Beckmann, P. Fasching, 2018, Geburtshilfe und Frauenheilkunde.

High-dose chemotherapy in germ cell tumours: a large single centre experience.

D. Huhn, W. Siegert, O. Rick, 1998, European journal of cancer.

State-ofthe-Art Paper Vox Sanguinis

D. Huhn, O. Rick, J. Beyer, 2011 .

Analysis of CD34‐Expressing Cells in Clinical Practice

D. Huhn, O. Rick, J. Beyer, 1998, Vox sanguinis.

Automated Collection of Peripheral Blood Stem Cells with the COBE Spectra for Autotransplantation

H. Heuft, O. Rick, S. Serke, 2000, Vox Sanguinis.

Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.

J Schleicher, C. Bokemeyer, L. Kanz, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

M. Lux, M. Beckmann, P. Fasching, 2018, Geburtshilfe und Frauenheilkunde.

High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.

C. Bokemeyer, O. Rick, A. Neubauer, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Rehabilitation of Cancer Survivors with Long-Term Toxicities

O. Rick, M. Reuss-Borst, J. Schmielau, 2017, Oncology Research and Treatment.

Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.

C. Bokemeyer, T. Gauler, M. Kuczyk, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.

C. Bokemeyer, R. Schirren, W. Berdel, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of Postchemotherapy Surgery in the Management of Patients With Liver Metastases From Germ Cell Tumors

C. Bokemeyer, L. Kanz, T. Gauler, 2005, Annals of surgery.

Labile Blood Components and Blood Donation

H. Heuft, O. Rick, S. Serke, 2000 .

Magnetic field therapy in patients with cytostatics‐induced polyneuropathy: A prospective randomized placebo‐controlled phase‐III study

O. Rick, H. Dertinger, G. Geiger, 2016, Bioelectromagnetics.

Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.

C. Bokemeyer, O. Rick, J. Hartmann, 2008, European journal of cancer.

Reintegrating cancer patients into the workplace.

O. Rick, U. Seifart, T. Dauelsberg, 2012, Deutsches Arzteblatt international.

Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer

M. Kuczyk, N. Schleucher, C. Kollmannsberger, 2000, Anti-cancer drugs.

Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

C. Bokemeyer, L. Kanz, C. Kollmannsberger, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

C. Bokemeyer, L. Kanz, F. Mayer, 2002, British Journal of Cancer.

Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.

C. Bokemeyer, L. Kanz, M. Kuczyk, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncological Rehabilitation and Cancer Survivorship

O. Rick, T. Langer, 2017, Oncology Research and Treatment.

The Six-Minute-Walk Test in assessing respiratory function after tumor surgery of the lung: a cohort study.

S. Bölükbas, M. Eberlein, J. Schirren, 2014, Journal of thoracic disease.

Mobilization of peripheral blood progenitor cells by disease-specific chemotherapy in patients with soft tissue sarcoma

D. Huhn, H. Riess, O. Rick, 1998, Bone Marrow Transplantation.

Bacterial Contamination of Autologous Bone Marrow: Reinfusion of Culture‐Positive Grafts Does Not Result in Clinical Sequelae during the Posttransplantation Course

D. Huhn, H. Heuft, O. Rick, 1998 .

Genitourinary tumors, non-prostate

S. J. Park, I. Tannock, S. Groshen, 2012 .

High‐dose salvage chemotherapy. Germ‐cell tumor treatment results in Germany

W. Siegert, O. Rick, J. Beyer, 1999, International journal of cancer.

Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.

C. Meisner, C. Bokemeyer, L. Kanz, 2003, European journal of cancer.

Clinical relevance of germ cell cancer cells detected by real time PCR in apheresis products of poor risk patients undergoing high dose chemotherapy.

C. Bokemeyer, J. Hartmann, O. Rick, 2010 .

Low frequency magnetic field therapy in patients with cytostatic‐induced polyneuropathy: A phase II pilot study

O. Rick, H. Dertinger, G. Geiger, 2015, Bioelectromagnetics.

Inverse relationship between patient peripheral blood CD34+ cell counts and collection efficiency for CD34+ cellsin two automated leukapheresis systems

H. Heuft, O. Rick, S. Serke, 2001, Transfusion.

Einfluss klinischer, sozialmedizinischer und psychologischer Faktoren auf die berufliche Reintegration von Patientinnen mit Brustkrebs 6 Monate nach der Rehabilitation

K. Fliessbach, H. Hass, C. Hoppe, 2021, Die Rehabilitation.

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

W. Siegert, N. Kröger, A. Zander, 2002, Haematologica.